Cardioprotective Effects of Paricalcitol Alone and in Combination With FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies-Reference-Cited by-同舟云学术

Cardioprotective Effects of Paricalcitol Alone and in Combination With FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies

Published:2018-10-17 Issue:1 Volume:32 Page:34-44
ISSN:0895-7061
Container-title:American Journal of Hypertension
language:en
Short-container-title:

Author:

Czaya Brian¹²,Seeherunvong Wacharee³,Singh Saurav¹,Yanucil Christopher¹²,Ruiz Phillip⁴,Quiroz Yasmir⁵,Grabner Alexander¹⁶,Katsoufis Chryso³,Swaminathan Sethuraman⁷,Abitbol Carolyn³,Rodriguez-Iturbe Bernardo⁵,Faul Christian¹²,Freundlich Michael³^ORCID

Affiliation:

1. Katz Family Drug Discovery Center and Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA

2. Division of Nephrology, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA

3. Division of Pediatric Nephrology, University of Miami Miller School of Medicine, Miami, Florida, USA

4. Department of Surgery and Immunopathology, University of Miami Miller School of Medicine, Miami, Florida, USA

5. Hospital Universitario, Servicio de Nefrologia y Laboratorio de Inmunobiologia, Instituto Venezolano de Investigaciones Científicas (IVIC)-Zulia, Maracaibo, Venezuela

6. Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA

7. Division of Pediatric Cardiology, University of Miami Miller School of Medicine, Miami, Florida, USA

Funder

National Institutes of Health

Fondo Nacional de Ciencia y Tecnologia

Publisher

Oxford University Press (OUP)

Subject

Internal Medicine

Link

http://academic.oup.com/ajh/article-pdf/32/1/34/27057034/hpy154.pdf

Reference54 articles.